7 JANUARY 1978 The meaning of the slow radiological healing of fractures or Looser zones in three of the seven patients in whom they were present is uncertain, as partially mineralised osteoid, which is radio-opaque, may appear around the fractures without there being any true remodelling and healing of trabecular bone. There was no improvement in histological osteomalacia in these cases.
Histologically, osteomalacia became worse in eight patients, three of whom showed an appreciable increase in osteitis fibrosa, and improved in only one. There is thus no evidence that phosphate treatment-or induction of osteitis fibrosa-promotes healing of osteomalacia.
The effect of phosphate treatment on myopathy and on bone pain, which was present in those with severe myopathy, is more difficult to assess. Assessment of myopathy is affected by the patient's motivation, which may have a large role in patients selected for special treatment. Nevertheless, two patients showed unequivocal improvement of myopathy, though not of bone histology; one was wheelchair-bound at the start of therapy through weakness and pain, was walking within three months, and is now clinically normal. 
SIDE EFFECTS OF DRUGS Erosive gastritis and duodenitis during continuous cimetidine treatment
Cimetidine accelerates the healing of duodenal ulcers, and symptomatic improvement is usually accompanied by endoscopic evidence of healing.1 2 We report an unusual mucosal appearance that developed in a patient receiving continuous cimetidine treatment.
Case report
A 43-year-old man presented with a typical history of peptic-ulcer disease of 14 years' duration. Barium-meal examination in January 1976 showed a shallow ulcer 5 mm in diameter on the anterior wall of the duodenal bulb with associated duodenal scarring and deformity. The gastric mucosa was normal apart from a mild antral gastritis. The patient agreed to participate in a six-month pharmacokinetic study of cimetidine, and treatment was started at 800 mg/day. Compliance with treatment was checked by tablet counts at monthly intervals. Symptomatic relief was complete within a few days and continued throughout the study period, during which no other drugs were given.
Three months after starting treatment repeat endoscopy showed complete healing of the ulcer. Widespread punctate erosive gastritis was noted, however, with altered blood at some erosion sites; there was also a florid duo- Examination showed gross -bilateral papilloedema with fundal haemorrhages, ataxia of gait, and dysdiadochokinesia. No other focal neurological abnormality was found, and there was no evidence of a peripheral neuropathy. The blood pressure was normal and the visual acuity was unimpaired. An x-ray film of the skull showed nothing abnormal. Computerised axial tomography (CAT scan) showed slightly dilated lateral ventricles, but no evidence of a cerebrospinal fluid (CSF) block. There was no suggestion of a mass lesion. The only change in his treatment was to withdraw perhexiline. Within four weeks the ataxia was better and within six weeks the fundi were normal. Lumbar puncture at this stage showed the CSF pressure to be 130 mm Hg and the protein content 1-0 g/l. He had been on perhexiline for 11 months, at a dose of 400 mg/day for nine months.
Case 2-A 43-year-old woman first developed angina pectoris in 1971. Coronary angiography showed normal coronary arteries, and she was subsequently treated with various beta-blockers and glyceryl trinitrate. Chest pains increased so perhexiline maleate 100 
Comment
Papilloedema has been seen before in patients taking perhexiline. Of seven patients considered to have peripheral neuropathy induced by perhexiline, three also had papilloedema.' These patients had been taking 300-400 mg/day for more than a year, and the papilloedema improved within six weeks of stopping the drug. In one patient the fundal appearances were seen to return completely to normal. Each of our three patients had been on perhexiline for at least 10 months, and the improvement in the fundal appearances coincided with stopping the drug, only the third patient showing a permanent impairment of visual acuity. Prolonged medication has been a feature in many cases of neuropathy3 and myopathy.4 Clearly, ataxia and headaches also occur fairly often as side effects of perhexiline without
